American Association for Cancer Research Aims to Raise Awareness about the Importance of Clinical Trial Participation
PHILADELPHIA, Sept. 24 /PRNewswire/ --
-- Most Americans with cancer would be receptive to participating in
clinical trials if they knew about them.
-- In a survey of 6,000 cancer patients, 85 percent were either unaware
or unsure that participation in a clinical trial was an option.
Seventy-five percent said they would have been willing to enroll had
they known it was possiblei.
-- This lack of knowledge is leading to a crisis in cancer drug
development with 80 percent of clinical trials in the U.S. being
delayed because of unfulfilled enrollmentii.
-- While clinical trials remain the only way to effectively test potential
new medications, fewer than 5 percent of adult cancer patients
participate in themiii. This lack of participation leads to delays in
clinical trials and slows patient access to new and possibly lifesaving
-- The American Association for Cancer Research (AACR), the proud
scientific partner of Stand Up to Cancer, a ground-breaking initiative
aimed at raising funds to accelerate cancer research and bringing new
therapies to patients more quickly, is committed to spreading knowledge
about cancer research and is on the front lines of the quest for
prevention and cure. AACR is taking a lead in raising awareness about
the urgent need to increase cancer clinical trial participation.
-- Clinical trials are not for everyone, but if you have been diagnosed
with any type of cancer, talk to your doctor about whether a clinical
trial may be right for you.
-- For information about AACR's progress toward the prevention and
|SOURCE American Association for Cancer Research (AACR)|
Copyright©2008 PR Newswire.
All rights reserved